New York is currently home to 4447 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Recruiting
This study has two phases, Phase I and Phase II. The main goal of the Phase I portion of this research study is to see what doses post-transplant inotuzumab ozogamicin can safely be given to subjects without having too many side effects. The Phase II portion of this study is to see what side effects are seen with medication after transplant. Inotuzumab ozogamicin is a combination of an antibody and chemotherapy which has been shown to have significant activity against relapsed/refractory acute... Read More
Gender:
ALL
Ages:
Between 16 years and 75 years
Trial Updated:
01/09/2025
Locations: Memorial Sloan Kettering Cancer Center, New York, New York
Conditions: Acute Lymphocytic Leukemia
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Recruiting
The purpose of this study is to find out if azacitidine and venetoclax are an effective treatment approach to get rid of or lower measurable residual disease (MRD) in people with acute myeloid leukemia (AML) who have received standard chemotherapy and are planning to have an allogeneic hematopoietic stem cell transplant (HSCT). Allogeneic HSCT, sometimes called a bone marrow transplant, involves receiving healthy blood-forming cells (stem cells) from a donor in order to replace the patient's imm... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/08/2025
Locations: Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack, New York
Conditions: Acute Myeloid Leukemia (AML)
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Recruiting
The researchers are doing this study to find out whether the combination of ruxolitinib and ulixertinib is a safe and effective treatment for people with myelofibrosis. The researchers will test different doses of ulixertinib to find the highest dose that causes few or mild side effects in participants when given in combination with ruxolitinib.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/08/2025
Locations: Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York
Conditions: Myelofibrosis
A Study of TLN-254 in Participants with Relapsed or Refractory T-cell Lymphoma
Recruiting
The primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/08/2025
Locations: Memorial Sloan Kettering Cancer Center, New York, New York
Conditions: Lymphoma
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Recruiting
This is a multicenter study that will be conducted at approximately 20 centers and up to 30 centers, if the sample size will be increased following interim assessment. The Q Therapeutic System (BQ 3.0) is a wearable medical device that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. The Q Therapeutic System (BQ 3.0) is in... Read More
Gender:
ALL
Ages:
Between 22 years and 80 years
Trial Updated:
01/08/2025
Locations: New York-Presbyterian Brooklyn Methodist Hospital Inpatient Rehabilitation Unit, Brooklyn, New York
Conditions: Ischemic Stroke
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Recruiting
This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
Gender:
ALL
Ages:
21 years and above
Trial Updated:
01/08/2025
Locations: St. Francis Hospital, Roslyn, New York
Conditions: Hernia, Ventral, Hernia, Inguinal
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
Recruiting
Among patients with stable ischemic heart disease who are referred for coronary angiography, a substantial proportion have non-obstructive coronary artery disease (CAD). Ischemia based on symptoms or stress testing may be due to coronary microvascular dysfunction in up to 40% of these patients. However, the mechanisms and optimal treatment of coronary microvascular dysfunction are unknown. Aberrant platelet activity and inflammation have been hypothesized as mechanisms of microvascular dysfuncti... Read More
Gender:
ALL
Ages:
Between 18 years and 125 years
Trial Updated:
01/08/2025
Locations: New York University School of Medicine, New York, New York
Conditions: Coronary Microvascular Disease, Ischemic Heart Disease, Myocardial Ischemia
A Study Comparing Quality of Life in Patients with Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
Recruiting
This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
01/08/2025
Locations: Memorial Sloan Kettering Cancer Center, New York, New York
Conditions: Lymphedema
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
Recruiting
The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
01/08/2025
Locations: Albany Medical Center, Albany, New York
Conditions: Intracranial Aneurysm
Building Community Resilience Program
Recruiting
Established in 2021, NYCEAL consists of approximately 40 organizational partners and 120 Community Health Workers (CHWs). Over the next four years (2024-2028), NYCEAL will work with this network to implement the following intervention: Building Community Resilience Program (BCR). To assess the impact of this intervention, an implementation research framework will be used, and pre- and post-surveys conducted, and other process evaluation measures collected. Changes in outcomes measures such as st... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/07/2025
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Resilience, Psychological, Burnout, Psychological, Stress, Psychological
Fatigue Reduction in Chronic Kidney Disease (CKD)
Recruiting
In this pilot trial, investigators will pilot test a cognitive behavioral intervention for acceptability and proof of concept for a larger future trial to be submitted for federal funding. This is a one-group design with qualitative and quantitative data collection integrated into the intervention.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/07/2025
Locations: NYU Langone Health, New York, New York
Conditions: Chronic Kidney Diseases, Fatigue
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Recruiting
Black and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven texting tool combined with peer recovery coach-supported text contact that delivers social services, stigma reduction, health habitus, and patient navigation content addressing social determinants of health to enhance receipt of buprenorphine in primary care among emergency department-enrolled Blac... Read More
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
01/07/2025
Locations: NYC Health + Hospitals, Bronx, New York
Conditions: Opioid Use Disorder